Andrew Witty

Andrew Witty
United States Senate Committee on Finance · Public domain · source
Name	Andrew Witty
Birth date	1964
Birth place	Keighley, West Riding of Yorkshire, England
Alma mater	University of Nottingham
Occupation	Business executive
Known for	CEO of GlaxoSmithKline

Andrew Witty is a British business executive and corporate leader best known for serving as chief executive officer of GlaxoSmithKline and later leading roles in global healthcare and investment. He has held senior positions that connected pharmaceutical firms, NHS initiatives, and international development partners. Witty's career spans corporate management, public-private collaboration, and executive leadership in multinational corporations.

Early life and education

Born in Keighley, West Riding of Yorkshire, Witty attended local schools near Bradford before reading economics at the University of Nottingham. During his student years he engaged with regional employers and joined Glaxo as a graduate trainee, a path similar to other executives who entered industry through graduate recruitment schemes. His formative years in Yorkshire overlapped with the industrial heritage of West Yorkshire and the business networks of Leeds and Manchester.

Career

Witty's professional trajectory began at Glaxo where he rose through commercial and managerial roles across markets including United States, Japan, and China. He held posts in sales, marketing, and later global management, aligning with peers who advanced through multinational rotations at firms like AstraZeneca and Roche. His international assignments involved interactions with regulatory agencies such as the Food and Drug Administration and European Medicines Agency, and with global health organizations including the World Health Organization and Bill & Melinda Gates Foundation.

Tenure at GlaxoSmithKline

Witty became CEO of GlaxoSmithKline in 2008 after serving in senior leadership at the merged entity following the Glaxo Wellcome and SmithKline Beecham consolidation. His tenure coincided with major events such as the global financial crisis of 2007–2008 and evolving patent landscapes affecting blockbuster products like Advair and Avastin competitor dynamics. He pursued strategies including portfolio restructuring, research and development prioritization, and emerging market expansion across India, Brazil, and China. Witty navigated regulatory and legal challenges involving agencies such as the Department of Justice (United States) and corporate compliance reforms similar to other sector cases like Pfizer and Merck & Co.. Under his leadership, GSK engaged in public-private partnerships with bodies like National Institutes of Health and global health alliances including GAVI to address access to medicines in low-income countries.

Post-GSK roles and later career

After stepping down from GSK leadership in 2017, Witty transitioned to roles in investment and public service, joining firms and institutions tied to global health and finance. He served in capacities at Optum and within holdings associated with UnitedHealth Group, and later took leadership at UnitedHealth Group subsidiaries and investment vehicles partnering with sovereign and private investors. His post-GSK appointments included board and advisory positions interacting with entities such as Harvard T.H. Chan School of Public Health, Imperial College London, and multilateral partners like the World Bank and International Finance Corporation on healthcare delivery and financing initiatives.

Leadership style and honors

Witty is noted for a collaborative, stakeholder-oriented leadership approach, drawing comparisons with executives like Sir Philip Hampton and Sir Martin Sorrell for corporate restructuring and public engagement. Observers linked his emphasis on access and compliance to precedents set by leaders at Novartis and Sanofi. He has received honors including a knighthood-level recognition pattern similar to recipients of Order of the British Empire ranks and has been listed in business rankings alongside figures such as Richard Branson and Stelios Haji-Ioannou for influence in British commerce. Witty has spoken at forums including the World Economic Forum in Davos and delivered lectures at institutions such as London School of Economics and University of Cambridge.

Personal life and philanthropy

Witty maintains ties to Yorkshire and has participated in philanthropic initiatives focusing on global health access, working with foundations like the Wellcome Trust and Clinton Foundation. His philanthropic and advisory work aligns with campaigns against diseases targeted by organizations such as Médecins Sans Frontières and PATH. He is married and balances private life with charitable involvement and advisory commitments to academia and industry bodies including UK Research and Innovation and regional investment partnerships in Leeds.

Category:British chief executives Category:Alumni of the University of Nottingham